Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Psoriasis (PsO)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Medical Research Institute, Alexandria University, Alexandria, Egypt
Contact: Study coordinator (Aliaa G. Aboulela, PhD) · aliaagamaleldin@alexu.edu.eg · +201002104138
Contact: Study coordinator (Eman M. Eleryan., MD.) · eman.elaryan@alexmed.edu.eg · +201001538935
Contact: Principal Investigator (Mohamed A. Alqasem, MSc)

Study leads

Ezzeldin A. Saleh, PhD
Study Chair
Medical Research Institute, Alexandria University
Gamaleldin A. Elsawaf, PhD
Study Director
Medical Research Institute, Alexandria University
Mohamed A. Alqasem, MSc
Principal Investigator
Medical Research Institute, Alexandria University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Autoimmune Diseases · Rheumatoid Arthritis (RA) · Psoriatic Arthritis (PsA)

Abroad (travel likely)RecruitingPHASE1

Charlestown, Australia · Birtinya, Australia

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Atopic Dermatitis (AD) · Psoriasis (PsO)

Abroad (travel likely)RecruitingPHASE1

Fargo, United States · Dallas, United States

PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

Psoriasis

Abroad (travel likely)Recruiting

Waltham, United States · Waltham, United States

Global Healthcare Study on Psoriasis

Psoriasis (PsO)

Abroad (travel likely)Recruiting

Zurich, Switzerland